Figure 4 of
Karring, Mol Vis 2007;
13:997-1004.Figure 4 of
Karring, Mol Vis 2007;
13:997-1004.
Figure 4. Immunoblotting of crude human plasma using the specific anti-TGFBIp134-236 antiserum
The immunoblot shows increasing amounts of crude human plasma diluted in 20 mM Tris-HCl (pH 7.4) and 100 mM NaCl. Each lane contains 20 μl of diluted crude plasma. Lane 1 contains 0.2 μg of purified porcine TGFBIp was used as a control. Lanes 2-6 have increasing amounts of crude human plasma. The indicated volumes refer to the amount of crude plasma. Lane 7 is the molecular weight standard.
